News
BOSTON, April 30, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the " Global Fluorescence Microscopy Market " is expected to grow from $968.5 million in 2024 to $1.3 billion by ...
2d
Clinical Trials Arena on MSNALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trialsDespite the failures, ALX Oncology remains hopeful about evorpacept and is focusing on combination trials with other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results